Institutional Ownership Viridian Therapeutics, Inc.\De (VRDN)
This table provides information about the institutional ownership of Viridian Therapeutics, Inc.\De (VRDN). We have compiled data on the 184 institutions that hold shares in the stock, with a total of 81.6 Million shares, which have been reported (via 13F filing form) to have a value of $2.35 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
245,759
shares
|
$7.06 Million
0.0% of portfolio
|
Q3 2025
Added 6.46%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Nov 14, 2025 Q3 2025 |
245,518
shares
|
$7.06 Million
0.83% of portfolio
|
Q3 2025
Reduced 47.76%
|
|
|
Principal Financial Group Inc
Des Moines, IA |
Nov 04, 2025 Q3 2025 |
213,329
shares
|
$6.13 Million
0.0% of portfolio
|
Q3 2025
Added 4.66%
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
208,246
shares
|
$5.98 Million
0.0% of portfolio
|
Q3 2025
Reduced 9.89%
|
|
|
Kopp Le Roy C
Bloomington, MN |
Jun 03, 2024 Q1 2024 |
205,640
shares
|
$5.91 Million
2.06% of portfolio
|
Q1 2024
New holding
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Nov 14, 2025 Q3 2025 |
202,821
shares
|
$5.83 Million
0.01% of portfolio
|
Q3 2025
New holding
|
|
|
Kopp Family Office, LLC
Bloomington, MN |
Oct 16, 2025 Q3 2025 |
193,830
shares
|
$5.57 Million
2.79% of portfolio
|
Q3 2025
Reduced 4.63%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
191,941
shares
|
$5.52 Million
0.0% of portfolio
|
Q3 2025
Reduced 4.21%
|
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
Dec 15, 2025 Q3 2025 |
175,251
shares
|
$5.04 Million
0.01% of portfolio
|
Q3 2025
Added 46.58%
|
|
|
Nuveen, LLC
Charlotte, NC |
Nov 12, 2025 Q3 2025 |
161,868
shares
|
$4.65 Million
0.0% of portfolio
|
Q3 2025
Reduced 27.49%
|
|
|
Macquarie Group LTD
Australia, C3 |
Nov 13, 2025 Q3 2025 |
154,739
shares
|
$4.45 Million
0.0% of portfolio
|
Q3 2025
Reduced 1.54%
|
|
|
Hennion & Walsh Asset Management, Inc.
|
Oct 22, 2025 Q3 2025 |
154,338
shares
|
$4.44 Million
0.13% of portfolio
|
Q3 2025
Reduced 8.31%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2025 Q3 2025 |
138,980
shares
|
$3.99 Million
0.0% of portfolio
|
Q3 2025
Reduced 26.89%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2025 Q3 2025 |
136,280
shares
|
$3.92 Million
0.0% of portfolio
|
Q3 2025
Added 129.29%
|
|
|
Russell Investments Group, Ltd.
|
Nov 13, 2025 Q3 2025 |
134,997
shares
|
$3.88 Million
0.0% of portfolio
|
Q3 2025
Added 53.61%
|
|
|
Knott David M Jr
Syosset, NY |
Nov 12, 2025 Q3 2025 |
116,574
shares
|
$3.35 Million
1.39% of portfolio
|
Q3 2025
Added 27.43%
|
|
|
Swiss National Bank
Zurich, V8 |
Nov 13, 2025 Q3 2025 |
110,700
shares
|
$3.18 Million
0.0% of portfolio
|
Q3 2025
Added 2.98%
|
|
|
Wells Fargo & Company
San Francisco, CA |
Nov 13, 2025 Q3 2025 |
105,880
shares
|
$3.04 Million
0.0% of portfolio
|
Q3 2025
Added 32.71%
|
|
|
Rhumbline Advisers
Boston, MA |
Nov 06, 2025 Q3 2025 |
104,360
shares
|
$3 Million
0.0% of portfolio
|
Q3 2025
Reduced 2.82%
|
|
|
Adar1 Capital Management, LLC
Austin, TX |
Nov 14, 2025 Q3 2025 |
101,704
shares
|
$2.92 Million
0.21% of portfolio
|
Q3 2025
Reduced 40.38%
|
|
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
Nov 14, 2025 Q3 2025 |
101,083
shares
|
$2.91 Million
0.09% of portfolio
|
Q3 2025
Reduced 9.38%
|
|
|
Propel Bio Management, LLC
Los Angeles, CA |
Nov 12, 2025 Q3 2025 |
90,000
shares
|
$2.59 Million
1.94% of portfolio
|
Q3 2025
New holding
|
|
|
Velan Capital Investment Management LP
Alpharetta, GA |
Nov 14, 2025 Q3 2025 |
86,500
shares
|
$2.49 Million
3.6% of portfolio
|
Q2 2025
New holding
|
|
|
Boothbay Fund Management, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
83,594
shares
|
$2.4 Million
0.03% of portfolio
|
Q3 2025
Reduced 54.18%
|
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Nov 14, 2025 Q3 2025 |
83,500
shares
|
$2.4 Million
0.0% of portfolio
|
Q3 2025
Added 6.35%
|
|